Skip to product information
CJC-1295 DAC 2mg
R 650.00
CJC-1295 Peptide is a modified growth hormone releasing hormone analogue designed to prolong growth hormone stimulation through extended receptor binding. This Peptide enhances endogenous growth hormone pulsatility and downstream IGF-1 signaling in endocrine research. CJC-1295 Peptide is widely studied in metabolism, recovery, and anabolic hormone regulation models.
Clinical Test Expectation
CJC-1295 DAC – Human Subjects : Long Release – Increased growth hormone secretion and IGF-1 Levels with no increase in prolactin. Increased body weight and length through increased protein synthesis. Increased muscle growth and bone density. Improved immune function, cognition and memory. Increased collagen production, fat loss and cellular repair and regeneration.
Strength
2mg per vial
Reconstitution
2ml of Bacteriostatic water into the vial of
CJC-1295 DAC.
